Debora Petrungaro Migueis

Debora Petrungaro Migueis

Auto-generated profile, based on publicly available information

Debora Petrungaro Migueis

Antonio Pedro University Hospital, Fluminense Federal University, Niterói, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2023 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
DMD.P. Migueis
D.P. Migueis
Maria-Cecilia LopesMaria-Cecilia Lopes
Maria-Cecilia Lopes
ECE. Casella
E. Casella
PSP.V. Soares
P.V. Soares
LSLeticia Azevedo Soster
Leticia Azevedo Soster
Karen SPRUYTKaren SPRUYT
Karen SPRUYT

7 January 2016 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
DMDebora Petrungaro Migueis
Debora Petrungaro Migueis
LTLuiz Claudio Santos Thuler
Luiz Claudio Santos Thuler
LLLucas Neves de Andrade Lemes
Lucas Neves de Andrade Lemes
CMChirlene Santos Souza Moreira
Chirlene Santos Souza Moreira
LJLucia Joffily
Lucia Joffily
MAMaria Helena de Araujo-Melo
Maria Helena de Araujo-Melo
Obstructive sleep apnea syndrome (OSAS) is a common disorder that can lead to cardiovascular morbidity and mortality, as well as to metabolic, neurological, and behavioral consequences. It is currently believed that nasal obstruction compromises the quality of sleep when it results in breathing disorders and fragmentation of sleep. However, recent studies have failed to objectively associate sleep quality and nasal obstruction. The aim of this systematic review is to evaluate the influence of nasal obstruction on OSAS and polysomnographic indices associated with respiratory events. Eleven original articles published from 2003 to 2013 were selected, which addressed surgical and non-surgical treatment for nasal obstruction, performing polysomnography type 1 before and after the intervention. In most trials, nasal obstruction was not related to the apnea-hypopnea index (AHI), indicating no improvement in OSAS with reduction in nasal resistance. However, few researchers evaluated other polysomnography indices, such as the arousal index and rapid eye movement (REM) sleep percentage. These could change with nasal obstruction, since it is possible that the nasal obstruction does not completely block the upper airways, but can increase negative intrathoracic pressure, leading to sleep fragmentation.

25 January 2022 in Journal of Oral Biosciences
Verified
Journal Article
Closed access
JSJúlia Gaspar de Oliveira Santos
Júlia Gaspar de Oliveira Santos
DMDébora Petrungaro Migueis
Débora Petrungaro Migueis
Jonatas Bussador do AmaralJonatas Bussador do Amaral
Jonatas Bussador do Amaral
Andre BachiAndre Bachi
Andre Bachi
ABAlexandre Coelho Boggi
Alexandre Coelho Boggi
RPRogério Pezato
Rogério Pezato

1 December 2019 in Sleep Medicine
Verified
Journal Article
Closed access
DMD.P. Migueis
D.P. Migueis
GLG.C.B. Lacerda
G.C.B. Lacerda
MLM.C. Lopes
M.C. Lopes
LAL.M.S.F. Azevedo-Soster
L.M.S.F. Azevedo-Soster
LTL.C.S. Thuler
L.C.S. Thuler
MAM.H. Araujo-Melo
M.H. Araujo-Melo

1 September 2021 in Sleep Medicine
Verified
Journal Article
Closed access
DMD.P. Migueis
D.P. Migueis
MLM.C. Lopes
M.C. Lopes
PIP.S.D. Ignacio
P.S.D. Ignacio
LTL.C.S. Thuler
L.C.S. Thuler
MAM.H. Araujo-Melo
M.H. Araujo-Melo
GLG.C.B. Lacerda
G.C.B. Lacerda

1 May 2012 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Closed access
PLP. M. Lago
P. M. Lago
NBN. Boéchat
N. Boéchat
DMD. P. Migueis
D. P. Migueis
AAA. S. Almeida
A. S. Almeida
LLL. C. Lazzarini
L. C. Lazzarini
JSJOSE R. LAPA E SILVA
JOSE R. LAPA E SILVA
Interleukin (IL) 10 and interferon-gamma (IFN-) levels in induced sputum supernatants of 21 tuberculosis (TB) patients at diagnosis and during chemotherapy were correlated to recurrence rates. IL-10 decreased until day 60 of treatment (T60), and between T60 and T180 it increased again in 7 cases (Pattern 1) and further decreased in 14 cases (Pattern 2). Follow-up of 69 months was performed in 20/21 cases; 6 had recurrence of TB, of which 5/7 (71%) had Pattern 1 and 1/13 (7.7%) Pattern 2 (OR 30.0, 95%CI 2.19411.3, P 0.0072). This was not observed for IFN-. High IL-10 levels at the end of treatment may function as a risk factor for TB recurrence.